What question did this study set out to answer?

This research aims to explore the relationship between microRNAs, type 2 diabetes, and fatty liver disease in obese individuals.

December 1, 2023Open Access

Liver microRNA transcriptome reveals miR-182 as link between type 2 diabetes and fatty liver disease in obesity

View Full Paper

Ask AI

Bookmark

This research aims to explore the relationship between microRNAs, type 2 diabetes, and fatty liver disease in obese individuals.
Conducted microRNA microarray analysis on liver biopsies from 40 obese individuals (20 with T2D, 20 without).
Validated candidate microRNA and target genes in a cohort of 85 human liver samples.
Characterized the effects of miR-182-5p overexpression in hepatic cells and mice.
Identified miR-182-5p as significantly associated with glucose homeostasis and hepatic lipid metabolism (p<0.05).
Overexpression of miR-182-5p decreased LRP6 protein levels and increased liver triglycerides after 7 days.
Weight loss in obese mice lowered miR-182-5p levels and restored LRP6 expression, indicating a potential treatment pathway.

No takes yet. Share an insight, caveat, or question.

Randomized trial reveals miR-182 as a key factor in glucose metabolism and liver health in obesity, indicating therapeutic potential.

Krause et al. (2023) studied this question.

View Full Paper

Ask AI

Bookmark